Back to search
FDAFDA · Food and drugs·Recall number D-0429-2024

Treprostinil Injection, 20 mg/20 mL (1 mg/mL), For Subcutaneous or Intravenous Infusion Only, 20 mL Multiple-Dose Vial, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-206-01

Published April 3, 2024 · Recall initiated: March 4, 2024

Summary

FDA records drug Class I recall D-0429-2024, published April 3, 2024 and initiated March 4, 2024. Recalling firm: Par Sterile Products LLC; Status: Ongoing; Reported quantity: 466 vials; Lot: Lot#: 57014; Exp, 04/30/2024. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Par Sterile Products LLC
Distributor
Nationwide in the USA
Lot
Lot#: 57014; Exp, 04/30/2024
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Treprostinil Injection, 20 mg/20 mL (1 mg/mL), For Subcutaneous or Intravenous Infusion Only, 20 mL Multiple-Dose Vial, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-206-01 recalled?

Yes. FDA published recall D-0429-2024 on April 3, 2024. Reported hazard: Presence of Particulate Matter.

What should I do if I have this product?

Voluntary: Firm initiated · Letter